Skip to main content

N,N-dimethyl-3-[2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]propan-1-amine

ADVERTISEMENT
Identification
Molecular formula
C18H28N4
CAS number
79982-18-4
IUPAC name
N,N-dimethyl-3-[2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]propan-1-amine
State
State

The compound exists as a solid at room temperature.

Melting point (Celsius)
132.00
Melting point (Kelvin)
405.15
Boiling point (Celsius)
250.00
Boiling point (Kelvin)
523.15
General information
Molecular weight
300.43g/mol
Molar mass
300.4280g/mol
Density
1.1200g/cm3
Appearence

The compound is typically found in a solid state at room temperature and has a crystalline appearance. It may appear as a white to off-white powder.

Comment on solubility

Solubility of N,N-dimethyl-3-[2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]propan-1-amine

The solubility of N,N-dimethyl-3-[2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]propan-1-amine can be quite intriguing given its complex structure. While specific solubility data may vary, several factors can influence its solubility:

  • Polarity: Compounds with polar functional groups tend to be more soluble in polar solvents, such as water.
  • Hydrogen Bonding: The presence of nitrogen atoms in the pyrrolidine and benzimidazole moieties can lead to potential hydrogen bonding interactions, enhancing solubility in aqueous environments.
  • Environmental pH: The solubility may also be affected by the pH of the solution, as certain forms of the compound may become ionized at different pH levels.
  • Temperature: Higher temperatures often increase solubility by providing energy to disrupt intermolecular forces.

In summary, while the solubility of this compound needs to be explored through experimental data, it is likely to exhibit solubility characteristics influenced by its unique molecular structure and environmental factors. As stated in many chemical contexts, "like dissolves like," highlighting the importance of considering the solvent type when assessing solubility.

Interesting facts

Interesting Facts about N,N-dimethyl-3-[2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]propan-1-amine

N,N-dimethyl-3-[2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]propan-1-amine, often abbreviated as DMBA, is a fascinating compound that showcases the vast potential of organic chemistry. Here are some intriguing aspects of this compound:

  • Pharmacological Interests: DMBA has garnered attention in pharmacology for its various potential therapeutic applications. The unique structure of the benzimidazole and pyrrolidine moieties contributes to its biological activity, making it an interesting candidate for drug development.
  • Versatile Chemical Structure: The presence of both a dimethylamino group and a benzimidazole ring offers multiple sites for chemical modification, which can lead to the discovery of even more active derivatives. This property makes it a valuable lead compound in medicinal chemistry.
  • Mechanism of Action: DMBA is believed to influence certain neurotransmitter systems, which is crucial for its proposed use in treating neurological disorders. Understanding how this compound interacts with receptors provides insights into its mechanism of action.
  • Research Implications: Ongoing research into DMBA emphasizes the importance of studying compounds with complex structures. The compound exemplifies how chemical modifications can lead to enhancements in potency and selectivity in pharmacological contexts.
  • Design of Novel Compounds: The synthetic pathways leading to DMBA can inspire chemists to devise novel compounds with desired properties. The creative methods used in its synthesis showcase the ingenuity of modern organic chemistry.

In summary, N,N-dimethyl-3-[2-(2-pyrrolidin-1-ylethyl)benzimidazol-1-yl]propan-1-amine is more than just a molecular formula; it represents a world of chemical possibilities and potential advancements in the field of medicinal chemistry. The study of such compounds not only enhances our understanding of chemistry but also paves the way for future innovations in drug design.